| Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer VP Balachandran, M Łuksza, JN Zhao, V Makarov, JA Moral, R Remark, ... Nature 551 (7681), 512-516, 2017 | 805 | 2017 |
| CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan C Vennin, P Mélénec, R Rouet, M Nobis, AS Cazet, KJ Murphy, ... Nature communications 10 (1), 3637, 2019 | 149 | 2019 |
| Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity F Newell, JS Wilmott, PA Johansson, K Nones, V Addala, ... Nature communications 11 (1), 5259, 2020 | 82 | 2020 |
| Germline and somatic variant identification using BGISEQ-500 and HiSeq X Ten whole genome sequencing AM Patch, K Nones, SH Kazakoff, F Newell, S Wood, C Leonard, ... PloS one 13 (1), e0190264, 2018 | 44 | 2018 |
| Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance F Newell, IP da Silva, PA Johansson, AM Menzies, JS Wilmott, V Addala, ... Cancer cell 40 (1), 88-102. e7, 2022 | 39 | 2022 |
| Association of serum uric acid level with ischemic stroke, stroke subtypes and clinical outcome. R Koppula, S Kaul, A Venkateswar Rao, A Jyothy, A Munshi Neurology Asia 18 (4), 2013 | 22 | 2013 |
| Genomic and molecular analyses identify molecular subtypes of pancreatic cancer recurrence SB Dreyer, R Upstill-Goddard, A Legrini, AV Biankin, S Allison, D Beraldi, ... Gastroenterology 162 (1), 320-324. e4, 2022 | 16 | 2022 |
| Three most common nonsynonymous UGT1A6* 2 polymorphisms (Thr181Ala, Arg184Serand Ser7Ala) and therapeutic response to deferiprone in β-thalassemia major patients S Dadheech, AV Rao, U Shaheen, MD Hussien, S Jain, A Jyothy, ... Gene 531 (2), 301-305, 2013 | 12 | 2013 |
| Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma J Creaney, AM Patch, V Addala, SA Sneddon, K Nones, IM Dick, YCG Lee, ... Genome Medicine 14 (1), 58, 2022 | 11 | 2022 |
| MS-275, a class 1 histone deacetylase inhibitor augments glucagon-like peptide-1 receptor agonism to improve glycemic control and reduce obesity in diet-induced obese mice S Bele, SB Girada, A Ray, A Gupta, S Oruganti, P Prakash Babu, ... Elife 9, e52212, 2020 | 11 | 2020 |
| Apert’s syndrome: study by whole exome sequencing RK Anjana Munshi, Preeti Khetarpal, Satrupa Das, Venkateshwar Rao, Monica ... Genes and Disease, 2017 | 2* | 2017 |
| Genomic profiling of non-small cell lung cancer: A pilot study from South India LA Jacob, KC Lakshmaiah, K Govindbabu, D Lokanatha, A Agarwal, ... International Journal 2 (2), 64, 2017 | 2 | 2017 |
| Comparison of actionable events detected in cancer genomes by whole-genome sequencing, in silico whole-exome and mutation panels P Ramarao-Milne, O Kondrashova, AM Patch, K Nones, LT Koufariotis, ... ESMO open 7 (4), 100540, 2022 | 1 | 2022 |
| Efficient detection and monitoring of pediatric brain malignancies with liquid biopsy based on patient-specific somatic mutation screening M Kojic, MK Maybury, N Waddell, LT Koufariotis, V Addala, A Millar, ... Neuro-oncology, noad032, 2023 | | 2023 |
| 204. THE TUMOUR IMMUNE MICROENVIRONMENT IN OESOPHAGEAL ADENOCARCINOMA HAS PROGNOSTIC SIGNIFICANCE J Lonie, S Brosda, L Aoude, V Bonazzi, K Patel, G Lampe, L Koufariotis, ... Diseases of the Esophagus 35 (Supplement_2), doac051. 204, 2022 | | 2022 |
| 280. MULTI-OMIC FEATURES OF OESOPHAGEAL ADENOCARCINOMA PATIENTS PRE-TREATED WITH PREOPERATIVE NEOADJUVANT THERAPY M Naeini, F Newell, LG Aoude, VF Bonazzi, K Patel, G Lampe, ... Diseases of the Esophagus 35 (Supplement_2), doac051. 280, 2022 | | 2022 |
| Generalising uncertainty improves accuracy and safety of deep learning analytics applied to oncology S MacDonald, H Foley, M Yap, RL Johnston, K Steven, LT Koufariotis, ... bioRxiv, 2022.07. 14.500142, 2022 | | 2022 |
| 89P Dissecting tumour-immune interactions in mesothelioma for identifying responders to immune checkpoint blockade V Addala, S Sneddon, I Dick, D Fennell, JV Pearson, B Robinson, ... Annals of Oncology 31, S1453, 2020 | | 2020 |
| Tracking genomic and transcriptomic features of oesophageal adenocarcinoma for improving patients outcome M Naeini, F Newell, LG Aoude, VF Bonazzi, K Patel, LT Koufariotis, ... ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 16, 84-84, 2020 | | 2020 |
| Therapeutic Opportunity in Cancers with Poor Survival V Addala | | 2020 |
john v pearsonQIMR Berghofer MRIVerified email at qimrberghofer.edu.au
